Index of reports
> Cases with Dyspnoea (106)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Velcade (Bortezomib) where reactions include dyspnoea. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 106 Next >>
Possible Velcade side effects in
Reported by a physician from France on 2012-08-23
Patient:
Reactions: Back Pain, Electrocardiogram QT Prolonged, Dyspnoea, Hypotension, Thrombocytopenia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 20 mg, unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-05-22
End date: 2012-05-29
JNJ-26481585
Dosage: 12 mg, unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-05-21
End date: 2012-05-31
Velcade
Dosage: 2.1 mg, unk
Indication: Multiple Myeloma
Start date: 2012-05-22
End date: 2012-05-29
Other drugs received by patient: Ceftriaxone; Primperan / 00041901 /; Acetaminophen; Zelitrex / 01269701 /; Fentanyl; Atracurium Besylate; Kardegic / 00002703 /; Oxycontin; Oxygen; Tranxene; Primperan / 00041901 /; Bumetanide; Crestor; Primperan / 00041901 /; Hydrocortisone; Ondansetron; Ondansetron; Ondansetron; Importal; Tramadol HCL; Noradrenaline / 00127501 /; Tramadol HCL; Morphine; Furosemide; Midazolam; Tramadol HCL
Possible Velcade side effects in
Reported by a physician from Italy on 2012-08-20
Patient:
Reactions: Dyspnoea, Anaemia, Pancytopenia, Thrombocytopenia, Asthenia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Velcade
Other drugs received by patient: Nitroglycerin; Bisoprolol Fumarate; Dexamethasone; Furosemide; Lasix; Dexamethasone
Possible Velcade side effects in female
Reported by a physician from United States on 2012-08-20
Patient: female, weighing 70.8 kg (155.8 pounds)
Reactions: Abdominal Pain, Hyperpyrexia, Anaphylactic Reaction, Chills, Pain, Hepatic Failure, Transaminases Increased, Splenic Infarction, Loss of Consciousness, Aortic Thrombosis, Off Label Use, Malaise, C-Reactive Protein Increased, Myositis, Dyspnoea, Hypotension, Arrhythmia, Lung Consolidation, Hypophosphataemia, Zygomycosis, Bacteraemia, Ventricular Tachycardia, Hyperammonaemia, Neutropenia, Hepatic Infarction, Shock, Infusion Related Reaction
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Cytarabine
Dosage: day 1,8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
Decadron Phosphate
Dosage: day 1
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
Doxil
Dosage: day 1
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
End date: 2007-10-23
Methotrexate
Dosage: day 1
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-01-01
End date: 2007-01-01
PEG-Asparaginase
Dosage: day 2, 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-25
End date: 2007-10-25
Velcade
Dosage: day 1, 4, 8 and 11
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
End date: 2007-10-23
Vincristine
Dosage: day 1,8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
End date: 2007-10-23
Possible Velcade side effects in 14 year old male
Reported by a physician from United States on 2012-08-20
Patient: 14 year old male, weighing 71.4 kg (157.1 pounds)
Reactions: Dyspnoea, Hypotension, Sepsis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-08-09
End date: 2012-08-10
Cytarabine
Dosage: 70 mg, cyclic
Start date: 2012-08-09
End date: 2012-08-09
Daunorubicin HCL
Dosage: 50 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-08-09
End date: 2012-08-09
Etoposide
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-08-09
End date: 2012-08-09
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-08-09
End date: 2012-08-09
Possible Velcade side effects in
Reported by a physician from Germany on 2012-08-17
Patient:
Reactions: Dyspnoea, Tachycardia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Velcade
Other drugs received by patient: Acyclovir; Dexamethasone; Pamidronate Disodium
Possible Velcade side effects in
Reported by a physician from France on 2012-08-16
Patient:
Reactions: Electrocardiogram QT Prolonged, Back Pain, Dyspnoea, Hypotension, Thrombocytopenia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 20 mg, unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-05-22
End date: 2012-05-29
JNJ-26481585
Dosage: 12 mg, unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-05-21
End date: 2012-05-31
Velcade
Dosage: 2.1 mg, unk
Indication: Multiple Myeloma
Start date: 2012-05-22
End date: 2012-05-29
Other drugs received by patient: Ceftriaxone; Primperan / 00041901 /; Bumetanide; Acetaminophen; Morphine; Atracurium Besylate; Ondansetron; Crestor; Fentanyl; Furosemide; Midazolam; Tranxene; Ondansetron; Tramadol HCL; Noradrenaline / 00127501 /; Hydrocortisone; Importal; Tramadol HCL; Kardegic / 00002703 /; Primperan / 00041901 /; Primperan / 00041901 /; Tramadol HCL; Zelitrex / 01269701 /; Oxycontin; Oxygen; Ondansetron
Possible Velcade side effects in
Reported by a physician from NEW Zealand on 2012-08-14
Patient:
Reactions: Dyspnoea, Diaphragmatic Paralysis
Drug(s) suspected as cause:
Velcade
Other drugs received by patient: Thalidomide; Dexamethasone
Possible Velcade side effects in female
Reported by a physician from United States on 2012-08-14
Patient: female, weighing 70.8 kg (155.8 pounds)
Reactions: Abdominal Pain, Rhabdomyolysis, Hyperpyrexia, Chills, Anaphylactic Reaction, Bone Pain, Hepatic Failure, Transaminases Increased, Loss of Consciousness, Aortic Thrombosis, Splenic Infarction, Hypokalaemia, Malaise, C-Reactive Protein Increased, Dyspnoea, Hypotension, Hypophosphataemia, Zygomycosis, Bacteraemia, Hyperammonaemia, Neutropenia, Hepatic Infarction, Lung Infiltration, Shock, Infusion Related Reaction
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 70 mg, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-01-01
End date: 2007-10-23
Decadron Phosphate
Dosage: 9 mg, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
End date: 2007-10-23
Doxorubicin HCL
Dosage: 107 mg, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
End date: 2007-10-23
Methotrexate Sodium
Dosage: unk, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-01-01
End date: 2007-01-01
Pegaspargase
Dosage: unk, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-25
Velcade
Dosage: 1.3 mg/m2, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
End date: 2007-10-23
Vincristine
Dosage: 2 mg, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
End date: 2007-10-23
Possible Velcade side effects in female
Reported by a physician from United States on 2012-08-10
Patient: female, weighing 62.0 kg (136.4 pounds)
Reactions: Blood Alkaline Phosphatase Increased, Pneumonia Fungal, Dyspnoea, Hypotension, Muscular Weakness, Febrile Neutropenia, Hypokalaemia, Dehydration, Hypoxia, Pulmonary Oedema, Hypoalbuminaemia, Neutrophil Count Decreased, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Decitabine
Dosage: 20 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-27
End date: 2012-05-06
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-27
End date: 2012-05-06
Possible Velcade side effects in
Reported by a physician from Germany on 2012-08-09
Patient:
Reactions: Dyspnoea, C-Reactive Protein Increased, General Physical Health Deterioration
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: unk
Indication: Multiple Myeloma
Start date: 2011-01-26
End date: 2012-07-18
Velcade
Dosage: unk
Indication: Multiple Myeloma
Start date: 2011-01-26
End date: 2012-07-18
Possible Velcade side effects in male
Reported by a physician from United States on 2012-08-09
Patient: male, weighing 31.8 kg (70.0 pounds)
Reactions: Abdominal Pain, Atelectasis, Disseminated Intravascular Coagulation, Acidosis, Pericardial Effusion, Activated Partial Thromboplastin Time Prolonged, Multi-Organ Failure, Left Ventricular Dysfunction, Pulmonary Oedema, Mediastinal Haemorrhage, Blood Creatinine Increased, Renal Failure Acute, Dyspnoea, Angina Pectoris, Alanine Aminotransferase Increased, Hypotension, Hypercalcaemia, Respiratory Failure, Embolism, Cardiac Failure, Aspartate Aminotransferase Increased, Ventricular Tachycardia, Ejection Fraction Decreased, Hypoalbuminaemia, Ventricular Fibrillation, Sinus Tachycardia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Ativan
Indication: Product Used FOR Unknown Indication
Cytarabine
Dosage: 100 mg/kg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-11
Daunorubicin HCL
Dosage: 50 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-05
Etoposide
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-05
Fentanyl
Indication: Product Used FOR Unknown Indication
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-01
Possible Velcade side effects in male
Reported by a physician from Italy on 2012-08-08
Patient: male
Reactions: Blood Bilirubin Increased, Liver Injury, Blood Alkaline Phosphatase Increased, Dyspnoea, Alanine Aminotransferase Increased, Malaise, Gamma-Glutamyltransferase Increased, C-Reactive Protein Increased, Aspartate Aminotransferase Increased, Cytomegalovirus Infection, Blood Creatinine Increased, Hepatitis B, Gravitational Oedema
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Alkeran
Dosage: 16mg per day
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-02-14
End date: 2012-02-17
Velcade
Dosage: 2.6mg per day
Indication: Multiple Myeloma
Start date: 2012-02-21
End date: 2012-02-28
Other drugs received by patient: Prednisone TAB; Acyclovir
Possible Velcade side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-02
Patient: female
Reactions: Abdominal Rigidity, Dyspnoea, Hepatic Failure, Hypoaesthesia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Velcade
Dosage: 1.3 mg/m2, unk
Indication: Product Used FOR Unknown Indication
Velcade
Dosage: 1.0 mg/m2, unk
Possible Velcade side effects in 66 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-30
Patient: 66 year old female, weighing 90.8 kg (199.8 pounds)
Reactions: Pulmonary Hypertension, Gastrointestinal Haemorrhage, Acute Myocardial Infarction, Clostridial Infection, Immunosuppression, Renal Failure Acute, Cardiac Failure Congestive, Pneumonia, Dyspnoea, Malnutrition, Febrile Neutropenia, Encephalopathy, Atrial Fibrillation, Urinary Tract Infection Enterococcal, Renal Failure, Respiratory Failure, Renal Tubular Necrosis, Asthenia, Hypogammaglobulinaemia
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Dexamethasone
Dosage: 2.8571 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-12-18
End date: 2011-06-02
Dexamethasone
End date: 2012-04-10
Prednisone
Indication: Multiple Myeloma
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-12-20
End date: 2011-06-09
Revlimid
Administration route: Oral
End date: 2012-05-01
Velcade
Dosage: .2714 milligram
Indication: Multiple Myeloma
Start date: 2010-12-12
End date: 2011-06-02
Velcade
End date: 2012-04-10
Other drugs received by patient: Lotrel; Pravastatin; Vitamin D; Coreg; Doxepin; Tricore; Betaseron; Acyclovir; Allopurinol; Aspirin; Heocyte; Metformin Hydrochloride; Warfarin Sodium; Doxil
Possible Velcade side effects in 78 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-26
Patient: 78 year old female, weighing 46.7 kg (102.7 pounds)
Reactions: Dyspnoea, Chest Pain
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 32 mg, unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-03-23
Velcade
Dosage: 1.5 mg, unk
Indication: Multiple Myeloma
Start date: 2012-03-19
Other drugs received by patient: Methadone Hydrochloride; Fluconazole; Metoclopramide; Vantin / 01043502 /; Losartan Potassium; Senna / 00142201 /; Valtrex; Norvasc; Miralax; Prilosec; Dilaudid; Magnesium Oxide
Possible Velcade side effects in male
Reported by a physician from United States on 2012-07-24
Patient: male, weighing 31.8 kg (70.0 pounds)
Reactions: Atelectasis, Abdominal Pain, Disseminated Intravascular Coagulation, Acidosis, Pericardial Effusion, Multi-Organ Failure, Activated Partial Thromboplastin Time Prolonged, Left Ventricular Dysfunction, Pulmonary Oedema, Mediastinal Haemorrhage, Blood Creatinine Increased, Renal Failure Acute, Dyspnoea, Angina Pectoris, Hypotension, Alanine Aminotransferase Increased, Hypercalcaemia, Embolism, Cardiac Failure, Respiratory Failure, Ventricular Tachycardia, Ejection Fraction Decreased, Aspartate Aminotransferase Increased, Hypoalbuminaemia, Ventricular Fibrillation, Sinus Tachycardia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Ativan
Dosage: unk
Indication: Product Used FOR Unknown Indication
Cytarabine
Dosage: unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-11
Cytarabine
Dosage: 100 mg/kg, bid
Start date: 2012-06-01
End date: 2012-06-03
Daunorubicin Hydrochloride
Dosage: 50 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-05
Etoposide
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-05
Fentanyl
Indication: Product Used FOR Unknown Indication
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-01
Possible Velcade side effects in
Reported by a physician from Italy on 2012-07-19
Patient:
Reactions: Dyspnoea, Injury, Fall
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Velcade
Possible Velcade side effects in 66 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-18
Patient: 66 year old female, weighing 90.8 kg (199.8 pounds)
Reactions: Pulmonary Hypertension, Gastrointestinal Haemorrhage, Death, Acute Myocardial Infarction, Clostridial Infection, Cardiac Failure Congestive, Immunosuppression, Renal Failure Acute, Pneumonia, Dyspnoea, Malnutrition, Atrial Fibrillation, Febrile Neutropenia, Encephalopathy, Urinary Tract Infection Enterococcal, Renal Failure, Respiratory Failure, Renal Tubular Necrosis, Asthenia, Hypogammaglobulinaemia
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Dexamethasone
Dosage: 2.8571 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-12-18
End date: 2011-06-02
Dexamethasone
End date: 2012-04-10
Prednisone
Indication: Multiple Myeloma
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-12-20
End date: 2011-06-09
Revlimid
Administration route: Oral
End date: 2012-05-01
Velcade
End date: 2012-04-10
Velcade
Dosage: .2714 milligram
Indication: Multiple Myeloma
Start date: 2010-12-12
End date: 2011-06-02
Other drugs received by patient: Doxil; Coreg; Pravastatin; Heocyte; Betaseron; Lotrel; Aspirin; Vitamin D; Warfarin Sodium; Allopurinol; Doxepin; Acyclovir; Metformin Hydrochloride; Tricore
Possible Velcade side effects in male
Reported by a consumer/non-health professional from United States on 2012-07-17
Patient: male, weighing 31.8 kg (70.0 pounds)
Reactions: Abdominal Pain, Acidosis, Pericardial Effusion, Left Ventricular Dysfunction, Hypocalcaemia, Renal Failure Acute, Pneumonitis, Dyspnoea, Angina Pectoris, Hypotension, Anaemia, Delirium, Tumour Lysis Syndrome, Respiratory Failure, Cardiac Failure, Aspartate Aminotransferase Increased, Ejection Fraction Decreased, Sinus Tachycardia, Hypertension
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Ativan
Dosage: unk
Indication: Product Used FOR Unknown Indication
Cytarabine
Dosage: 100 mg/kg, bid
Start date: 2012-06-01
End date: 2012-06-03
Cytarabine
Dosage: unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-11
Daunorubicin Hydrochloride
Dosage: 50 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-05
Etoposide
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-05
Fentanyl
Indication: Product Used FOR Unknown Indication
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-01
Possible Velcade side effects in
Reported by a consumer/non-health professional from United States on 2012-07-16
Patient:
Reactions: Vomiting, Dyspnoea, Nausea, Pyrexia, Cardiomyopathy, Renal Failure Chronic, Weight Increased, Tumour Lysis Syndrome, Fatigue, Respiratory Failure, Vitamin B12 Deficiency, Alopecia, Ejection Fraction Decreased, Arteriosclerosis Coronary Artery, Respiratory Tract Infection, Cardiac Failure Congestive
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 20 mg, cyclic
Indication: Multiple Myeloma
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Multiple Myeloma
Start date: 2007-11-05
End date: 2007-12-03
Other drugs received by patient: OS-CAL / 00108001 /; Colace; Nexium; Synthroid; Allopurinol; Lasix; Lisinopril; Lovenox; Aspirin
Possible Velcade side effects in
Reported by a physician from Finland on 2012-07-13
Patient:
Reactions: Off Label Use, Dyspnoea, Coronary Artery Disease
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Velcade
Other drugs received by patient: Dexamethasone; Epoetin Zeta
Possible Velcade side effects in 66 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-13
Patient: 66 year old female, weighing 90.8 kg (199.8 pounds)
Reactions: Pulmonary Hypertension, Gastrointestinal Haemorrhage, Death, Acute Myocardial Infarction, Clostridial Infection, Renal Failure Acute, Immunosuppression, Cardiac Failure Congestive, Pneumonia, Dyspnoea, Malnutrition, Febrile Neutropenia, Atrial Fibrillation, Encephalopathy, Urinary Tract Infection Enterococcal, Renal Failure, Respiratory Failure, Renal Tubular Necrosis, Asthenia, Hypogammaglobulinaemia
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Dexamethasone
Dosage: 2.8571 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-12-18
End date: 2011-06-02
Dexamethasone
End date: 2012-04-10
Prednisone
Indication: Multiple Myeloma
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-12-20
End date: 2011-06-09
Revlimid
Administration route: Oral
End date: 2012-05-01
Velcade
End date: 2012-04-10
Velcade
Dosage: .2714 milligram
Indication: Multiple Myeloma
Start date: 2010-12-12
End date: 2011-06-02
Other drugs received by patient: Betaseron; Lotrel; Coreg; Doxepin; Vitamin D; Warfarin Sodium; Pravastatin; Doxil; Acyclovir; Allopurinol; Heocyte; Tricore; Aspirin; Metformin Hydrochloride
Possible Velcade side effects in
Reported by a physician from United Kingdom on 2012-07-10
Patient:
Reactions: Off Label Use, Dyspnoea, Hypotension, Chest Pain, Pleural Effusion, Troponin Increased, Pyrexia, Myocardial Infarction
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Velcade
Other drugs received by patient: Bendroflumethiazide; Codeine Sulfate; Dexamethasone; Gabapentin; Ibuprofen; Bisacodyl; Acetaminophen; Pamidronate Disodium; Amitriptyline HCL; Diazepam; Enoxaparin; Tramadol HCL
Possible Velcade side effects in
Reported by a consumer/non-health professional from United States on 2012-07-09
Patient:
Reactions: Dyspnoea, Anaemia, General Physical Health Deterioration, Oesophageal Haemorrhage, Thrombocytopenia, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 8 mg, cyclic
Indication: Multiple Myeloma
Start date: 2010-08-30
End date: 2011-11-04
Doxorubicin HCL
Dosage: 9 mg/m2, cyclic
Indication: Multiple Myeloma
Start date: 2011-08-30
End date: 2011-11-04
Velcade
Dosage: 1.3 mg, cyclic
Indication: Multiple Myeloma
Start date: 2011-08-30
End date: 2011-11-04
Other drugs received by patient: Moxonidin; Amlodipine; Finasterid Orion; Metoprolol Tartrate; Ramipril; Allopurinol; Levothyroxine Sodium; Calcivit D; Pantozol / 01263202 /; Hydromorphone HCL; Decostriol; Prednisone TAB; Tamsulosin HCL; Torsemide; Folsan
Possible Velcade side effects in female
Reported by a physician from United States on 2012-07-06
Patient: female, weighing 92.0 kg (202.4 pounds)
Reactions: White Blood Cell Count Decreased, Dyspnoea, Anaemia, Febrile Neutropenia, Muscular Weakness, Acidosis, Renal Failure Chronic, Fatigue, Sepsis, Platelet Count Decreased, Hypoxia, Neutrophil Count Decreased, Lymphocyte Count Decreased, Decreased Appetite
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Decitabine
Dosage: 20 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-02
End date: 2012-06-08
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-02
End date: 2012-06-06
Possible Velcade side effects in female
Reported by a consumer/non-health professional from United States on 2012-07-06
Patient: female
Reactions: Back Pain, Dyspnoea, Pain in Extremity, Bone Pain, Anxiety, Fatigue, Activities of Daily Living Impaired, Coordination Abnormal, Depression, Asthenia
Drug(s) suspected as cause:
Velcade
Possible Velcade side effects in
Reported by a consumer/non-health professional from United States on 2012-07-05
Patient:
Reactions: Respiratory Disorder, Dyspnoea
Drug(s) suspected as cause:
Velcade
Possible Velcade side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-05
Patient: male
Reactions: Cardio-Respiratory Arrest, Dyspnoea
Adverse event resulted in: death
Drug(s) suspected as cause:
Dexamethasone Sodium Phosphate
Dosage: 20 mg, cyclic
Indication: Multiple Myeloma
Lenalidomide
Dosage: 25 mg, cyclic
Indication: Multiple Myeloma
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Multiple Myeloma
Start date: 2010-09-17
End date: 2010-09-30
Vorinostat
Dosage: 400 mg, cyclic
Indication: Multiple Myeloma
Other drugs received by patient: Fish OIL; Aspirin; Fenofibrate; Multi-Vitamins; Colace; Loratadine; Levothyroxine Sodium; Methocarbamol
Possible Velcade side effects in
Reported by a pharmacist from Canada on 2012-06-29
Patient:
Reactions: Dyspnoea, C-Reactive Protein Increased, Lung Infiltration, Oxygen Saturation Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Velcade
Other drugs received by patient: Vitamin D; Tylenol (Caplet); Cyclophosphamide; Aspirin; Glucosamine; Omega 3 / 01334101 /; Calcium; Centrum / 00554501 /; Synthroid; Lipitor; Dexamethasone; Fish OIL
Possible Velcade side effects in 62 year old female
Reported by a physician from United States on 2012-06-27
Patient: 62 year old female, weighing 62.0 kg (136.4 pounds)
Reactions: Pneumonia Fungal, Blood Alkaline Phosphatase Increased, Dyspnoea, Hypotension, Febrile Neutropenia, Muscular Weakness, Hypokalaemia, Dehydration, Hypoxia, Hypoalbuminaemia, Pulmonary Oedema, Neutrophil Count Decreased, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Decitabine
Dosage: 20 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-27
End date: 2012-05-06
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-27
End date: 2012-05-06
Page 1 Next >>
|